HbA1c and Plasma Transforming Growth Factor-Beta 1 in Type-2 Diabetes Mellitus Patients
| Main Authors: | Pradana Zaky Romadhon, Ari Sutjahjo, Hermina Novida, Soebagijo Adi Soelistijo, Sony Wibisono, Jongky Hendro Prajitno, Askandar Tjokroprawiro |
|---|---|
| Format: | Article PeerReviewed Book |
| Bahasa: | eng |
| Terbitan: |
Yerevan State Medical University
, 2019
|
| Subjects: | |
| Online Access: |
http://repository.unair.ac.id/96985/1/hbaic%20and%20plasma.pdf http://repository.unair.ac.id/96985/2/HbA1c%20and%20Plasma%20Transforming.pdf http://repository.unair.ac.id/96985/3/HbA1c%20and%20Plasma%20Transforming%20Growth%20Factor-Beta%201%20in%20Type-2%20Diabetes%20Mellitus%20Patients.pdf http://repository.unair.ac.id/96985/ https://ysmu.am/website/documentation/files/38fce58d.pdf |
Daftar Isi:
- Background: The diabetic microvascular pathophysiology is associated with many chronic inflammatory processes triggered by some cytokines and growth factors. Transforming Growth Factor Beta-1 (TGFβ-1) is considered to be a key mediator of the pathogenesis of microvascular complications associated with chronic hyperglycemia. We analyzed the correlation between HbA1c and TGFβ-1 plasma levels in type-2 diabetes mellitus (T2DM) patients. Methods: We enrolled T2DM patients over the age of 18, then HbA1c level from venous blood samples supplemented with anticoagulants was measured by using HPLC (High-Performance Liquid Chromatography). TGFβ-1 examination was performed by using ELISA (Enzyme-Linked Immunosorbent Assay) and Human TGFβ-1 quantizing ELISA (R&D) reagent. Data were analyzed using Spearman correlation test. Results: The number of research subjects was 30 patients. The median of HbA1c levels were 7.15% (4.7-13.6%). Median TGFβ-1 plasma levels were 150.8 pg/mL (23.6-2089.2 pg / mL). Spearman’s correlation test showed a strong and significant positive correlation between HbA1c and TGFβ-1 plasma levels in patients with T2DM (rs = 0.637; p <0.001). Conclusion: There was a strong and significant positive correlation between HbA1c and TGFβ-1 plasma levels in T2DM patients.